Posted by Michael Wonder on 17 Jan 2022
Swissmedic grants temporary authorisation to Xevudy for COVID-19 patients
14 January 2022 - Corona medication Xevudy from GSK (sotrovimab) granted temporary authorisation in Switzerland
Swissmedic has granted temporary authorisation to the medicinal product Xevudy, the prescription of which was already permitted in Switzerland under COVID-19 Ordinance 3.
